Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Natalie Wong(Chinese University of Hong Kong), P. J. Johnson, Yasutaka Hayashi(Tokyo Medical and Dental University), L F Fung, Vanesse Wong, Joseph W.Y. Lau(Chinese University of Hong Kong), S Yuna, E. Pang(Chinese University of Hong Kong), Z. Sheng(Wenzhou Medical University), Elizabeth J. Perlman(Lurie Children's Hospital), Wenxue Wang(Zero to Three), Paul B.S. Lai(Chinese University of Hong Kong)
PubMed
October 1, 2000
Cited by 83
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
|Proceedings of the National Academy of Sciences|2015|818
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
|Proceedings of the National Academy of Sciences|2015|770
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services
|British journal of surgery|2020|719